ICRM
DXCM icon

Insight Capital Research & Management’s DexCom DXCM Stock Holding History

Insight Capital Research & Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-459,284
Closed -$4.75M – 132
2014
Q1 		$4.75M Buy
459,284
+32,328
+8% +$334K 1.09% 39
2013
Q4 		$3.78M Buy
+426,956
New +$3.38M 0.85% 49

Other funds holding DXCM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Insight Capital Research & Management's DXCM Position: Q2 2014 in Review

Insight Capital Research & Management sold out of DexCom (DXCM) in Q2 2014, closing a stake of 459,284 shares — an estimated $4.75M sold.

Insight Capital Research & Management first reported a position in DXCM in Q4 2013 and held it in 2 quarters. The position peaked at $4.75M in Q1 2014. 190 funds tracked by Wall St. Rank hold DXCM as of Q2 2014.

  • Insight Capital Research & Management reported no remaining DexCom position as of Q2 2014 after selling out during the quarter.
  • Insight Capital Research & Management sold 459,284 DexCom shares in Q2 2014, an estimated $4.75M.
  • Insight Capital Research & Management first reported a position in DexCom in Q4 2013 and held it in 2 quarters.
  • Insight Capital Research & Management's DexCom position peaked at $4.75M in Q1 2014.
  • 190 funds tracked by Wall St. Rank held DexCom as of Q2 2014.

Based on Insight Capital Research & Management's 13F filing for Q2 2014, filed 13 Aug 2014.